Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

236 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Intravitreal aflibercept 8 mg in neovascular age-related macular degeneration (PULSAR): 48-week results from a randomised, double-masked, non-inferiority, phase 3 trial.
Lanzetta P, Korobelnik JF, Heier JS, Leal S, Holz FG, Clark WL, Eichenbaum D, Iida T, Xiaodong S, Berliner AJ, Schulze A, Schmelter T, Schmidt-Ott U, Zhang X, Vitti R, Chu KW, Reed K, Rao R, Bhore R, Cheng Y, Sun W, Hirshberg B, Yancopoulos GD, Wong TY; PULSAR Investigators. Lanzetta P, et al. Lancet. 2024 Mar 23;403(10432):1141-1152. doi: 10.1016/S0140-6736(24)00063-1. Epub 2024 Mar 7. Lancet. 2024. PMID: 38461841 Clinical Trial.
TENAYA and LUCERNE: Two-Year Results from the Phase 3 Neovascular Age-Related Macular Degeneration Trials of Faricimab with Treat-and-Extend Dosing in Year 2.
Khanani AM, Kotecha A, Chang A, Chen SJ, Chen Y, Guymer R, Heier JS, Holz FG, Iida T, Ives JA, Lim JI, Lin H, Michels S, Quezada Ruiz C, Schmidt-Erfurth U, Silverman D, Singh R, Swaminathan B, Willis JR, Tadayoni R; TENAYA and LUCERNE Investigators. Khanani AM, et al. Ophthalmology. 2024 Feb 19:S0161-6420(24)00134-9. doi: 10.1016/j.ophtha.2024.02.014. Online ahead of print. Ophthalmology. 2024. PMID: 38382813 Free article.
Prevalence and causes of vision loss in East Asia: 1990-2010.
Wong TY, Zheng Y, Jonas JB, Flaxman SR, Keeffe J, Leasher J, Naidoo K, Pesudovs K, Price H, White RA, Resnikoff S, Taylor HR, Bourne RR; Vision Loss Expert Group of the Global Burden of Disease Study. Wong TY, et al. Br J Ophthalmol. 2014 May;98(5):599-604. doi: 10.1136/bjophthalmol-2013-304047. Epub 2014 Jan 3. Br J Ophthalmol. 2014. PMID: 24390167 Review.
Prevalence and causes of vision loss in Central and South Asia: 1990-2010.
Jonas JB, George R, Asokan R, Flaxman SR, Keeffe J, Leasher J, Naidoo K, Pesudovs K, Price H, Vijaya L, White RA, Wong TY, Resnikoff S, Taylor HR, Bourne RR; Vision Loss Expert Group of the Global Burden of Disease Study. Jonas JB, et al. Br J Ophthalmol. 2014 May;98(5):592-8. doi: 10.1136/bjophthalmol-2013-303998. Epub 2014 Jan 23. Br J Ophthalmol. 2014. PMID: 24457361 Review.
A Collaborative Retrospective Study on the Efficacy and Safety of Intravitreal Dexamethasone Implant (Ozurdex) in Patients with Diabetic Macular Edema: The European DME Registry Study.
Rosenblatt A, Udaondo P, Cunha-Vaz J, Sivaprasad S, Bandello F, Lanzetta P, Kodjikian L, Goldstein M, Habot-Wilner Z, Loewenstein A; ARTES Study Group. Rosenblatt A, et al. Among authors: lanzetta p. Ophthalmology. 2020 Mar;127(3):377-393. doi: 10.1016/j.ophtha.2019.10.005. Epub 2019 Oct 10. Ophthalmology. 2020. PMID: 31932090 Free article.
The role of OCT-A in retinal disease management.
Rodríguez FJ, Staurenghi G, Gale R; Vision Academy Steering Committee. Rodríguez FJ, et al. Graefes Arch Clin Exp Ophthalmol. 2018 Nov;256(11):2019-2026. doi: 10.1007/s00417-018-4109-3. Epub 2018 Sep 3. Graefes Arch Clin Exp Ophthalmol. 2018. PMID: 30175386 Free PMC article. Review.
236 results